Skip to content

FLEURUS PHARMA

Absorbed by MULTIPHARMA on 06-12-2018 KBO/BCE: BE 0875.864.171

Annual accounts 2017

full format, filed on 14-08-2018, 14 days late
€68,264
▼ 20.1%
€13,111
▲ €23,889
€66,956
▲ 55.1%
€59,919
▲ 183%
35.7%
▲ 3.4 percentage points
10.27
▲ 3.23

Money flows

no detail for 2017

Balance sheet

balance sheet total €656,345 on 31-12-2017
What the company ownsHow it is paid for

in euro

Staff

Staff costs divided by the average number of full-time equivalents.

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend201720162015201420132012201120102009200820072006
66,95643,172120,937169,045151,587134,07279,99188,373113,708126,94494,767116,849
59,91921,162166,106141,004124,11195,97853,28260,90383,85291,15356,31685,097
06,82024,8354191,15574,488450,69139,847108,02512,8751,977860,453
---24,84792,49335,860-144,543104,55968,063-58,83467,233-24,764-
295,160277,335293,297190,30094,11319,213-136,894-19,828-92,285-116,437-152,995-153,164
--2.5%-----1.8%2.6%2.7%---
35.7%32.3%30.5%23.4%17.6%14.3%10.5%28.7%22.5%21.2%20.8%20.9%
10.277.043.252.331.531.100.820.930.660.690.520.58
10.277.042.511.730.890.570.370.610.350.450.270.35
1.802.102.273.274.705.978.482.483.443.723.803.78
2.6%-14.4%24.5%21.8%13.6%-6.9%-32.7%0.9%-0.3%3.2%-14.6%3.9%
0.9%-4.6%7.5%5.1%2.4%-1.0%-3.4%0.2%-0.1%0.7%-3.0%0.8%
-58 days----21 days23 days21 days---
166 days6 days----108 days27 days24 days---

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend201720162015201420132012201120102009200820072006
Balance sheet: assets
20/58 656,345706,435854,073841,396876,469927,1371.3m656,471830,800886,018871,554995,802
21/28 329,341383,186430,316507,630605,211707,306738,157385,437653,884630,280702,647783,481
21 ---33,10066,20099,300132,400165,500198,600231,700264,800297,900
22/27 329,341383,186430,316474,530539,011608,006605,551219,731455,078398,374437,641485,375
22 289,485330,442247,606266,140284,666303,192267,677130,206343,879262,945284,634306,323
23 --116,973135,984156,790181,818187,2354,1507,77013,68425,82136,590
24 39,85652,74465,73772,40697,556122,997150,63985,375103,428121,744127,186142,463
28 ------206206206206206206
29/58 327,004323,249423,757333,766271,257219,831610,133271,033176,916255,739168,907212,321
3 --96,80485,265113,142104,803335,77493,25684,02589,46680,42584,825
30/36 --96,80485,265113,142104,803335,77493,25684,02589,46680,42584,825
40/41 117,92768,37972,12761,95264,06156,83371,62179,59962,77677,32266,76476,015
40 --71,82161,95263,51956,62664,40472,64862,67573,89461,76473,895
41 117,92768,379306-5422077,2176,9501013,4295,0002,120
50/53 -254,870----------
54/58 209,077-161,701186,54894,05558,195202,73898,17930,11688,95021,71746,481
490/1 --93,124--------5,000
Balance sheet: equity and liabilities
10/49 656,345706,435854,073841,396876,469927,1371.3m656,471830,800886,018871,554995,802
10/15 234,133228,059260,847196,890153,886133,025142,179188,606186,970187,539181,629208,125
10/11 200,000200,000200,000200,000200,000200,000200,000200,000200,000200,000200,000200,000
100 200,000200,000200,000200,000200,000200,000200,000200,000200,000200,000200,000200,000
13 3,9103,6063,606406406406406406406406406406
130 3,9103,6063,606406406406406406406406406406
14 30,22324,45357,241-3,516-46,520-67,381-58,227-11,800-13,436-12,867-18,7777,719
17/49 422,212478,376593,226644,506722,582794,1121.2m467,865643,830698,479689,925787,678
17 390,368432,462462,766500,725543,388593,178459,083176,414374,629326,304367,951422,192
170/4 390,368432,462462,766500,725543,388593,178459,083176,414374,629326,304367,951422,192
42/48 31,84445,914130,460143,466177,144200,619747,027290,861269,201372,175321,902365,485
42 29,73230,61837,95942,56349,79047,89144,24423,10950,59955,42354,24147,835
43 -----------19,715
430/8 -----------19,715
44 2,1126,10939,02218,63045,56369,388284,69573,69460,964114,22658,24977,605
440/4 2,1126,10939,02218,63045,56369,388284,69573,69460,964114,22658,24977,605
45 -1,65444,29614,93512,48713,80119,60111,20310,67411,33212,49411,616
450/3 -1,65425,3343,0841,4583,0686,6261,6852,9963,9903,0701,715
454/9 --18,96311,85011,02910,73312,9749,5187,6787,3429,4249,900
47/48 -7,5339,18367,33869,30569,538398,486182,855146,965191,194196,919208,715
492/3 ---3152,050315-590--72-
Income statement
70 -433,300----1.1m1.1m1.1m---
76A --101,676---1,7368,372----
9900 68,26485,406232,566261,663236,425214,068155,548159,050173,377178,394166,641187,168
60/61 4,639396,404----964,030987,317930,006---
62 17538,854111,62790,77984,83879,66775,32270,67759,66951,45071,72170,188
630 53,84553,950102,14998,000103,249105,13399,70859,26784,42185,24382,81176,972
640/8 1,1333,38011,838-329235---153132
9901 13,111-10,77818,78871,04548,33728,940-19,71729,10629,28741,70211,95639,876
75/76B 341003671983,2511,0833,0583,7354,4672,4422,593381
75 341003671983,2511,0833,0583,7354,4672,4422,593381
65/66B 7,06722,10633,49128,10330,58939,01333,10839,57734,32336,62841,04531,171
65 7,06722,10633,49128,10330,58939,01333,10839,57734,32336,62841,04531,171
9903 6,078-32,78487,34143,13921,000-8,990-48,0311,636-5697,515-26,4969,086
67/77 4423,384136138164-1,605--1,605-961
9904 6,074-32,78863,95743,00420,861-9,155-46,4261,636-5695,910-26,4968,125
9905 6,074-32,78863,95743,00420,861-9,155-46,4261,636-5695,910-26,4968,125
Appropriation of the result
9906 30,52724,45360,441-3,516-46,520-67,381-58,227-11,800-13,436-12,867-18,7778,125
691/2 304-3,200--------406
6920 304-3,200--------406
Social balance sheet
9087 -0.82.321.81.81.71.71.31.31.31.9
Hours worked1013 -1,5284,5053,8483,5753,4612,9572,9632,2522,2223,1683,477
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

Source: Annual accounts 2017 (PDF), filed on 14-08-2018.

Filings

each dot is a set of accounts, on the day it reached the National Bank

The accounts were filed on 14-08-2018. The deadline was 31-07-2018, 7 months after the close on 31-12-2017. Source: NBB, 2018-45900522.

Financial year Type Filed Reference Document
31-12-2017 full format 14-08-2018 2018-45900522 PDF
31-12-2016 full format 28-08-2017 2017-53200382 PDF
31-12-2015 full format 20-07-2016 2016-35000022 PDF
31-12-2014 full format 31-07-2015 2015-40100169 PDF
31-12-2013 full format 05-08-2014 2014-40300275 PDF
31-12-2012 full format 13-08-2013 2013-42400391 PDF
31-12-2011 full format 13-07-2012 2012-30400233 PDF
31-12-2010 full format 30-08-2011 2011-51500201 PDF
31-12-2009 full format 03-11-2010 2010-60000025 PDF
31-12-2008 full format 13-08-2009 2009-58700210 PDF
31-12-2007 full format 17-10-2008 2008-78800112 PDF
31-12-2006 full format 06-07-2007 2007-37200287 PDF

Insights on FLEURUS PHARMA

The operating result for 2017 is a profit of €13,111, after a loss of €10,778 in 2016.

Debt's share of the balance-sheet total falls from 67.7% to 64.3%. Equity is higher and debt is lower.